PointCross Life Sciences

PointCross Life Sciences, Inc. delivers proven technology to support drug safety development and translational medical analytics through a suite of informatics offerings. These include safety biomarker detection and analytics, data validation, regulatory reviews and submissions support, and study data standardization services. Our clients include global BioPharma companies as well as the FDA. PointCross Life Sciences' DSIMS (Drug Safety Information Management Suite) is based on the SEND data standard, with extensions to support other relevant nonclinical and clinical study data. DSIMS is the engine for the FDA's NIMS (Nonclinical Information Management Solution) which includes: a unified data and metadata repository; search, discovery and analytics functions; and viewing, graphing and reporting for nonclincial safety data. DSIMS is available as an enterprise or cloud hosted solution. PointCross Life Sciences, Inc. is a wholly owned subsidiary of PointCross, Inc.. which was founded in 1999.